Highly variable medicines - specific aspects of bioequivalence studies

Highly variable medicines - specific aspects of bioequivalence studies

At present a specific group of medicines - highly variable medicines - is distinguished based on intraindividual variability data (CVintra > 30%). It is quite difficult to confirm therapeutic equivalence of highly variable medicines by pharmacokinetic bioequivalence studies, and quite a large num...

Full description

Bibliographic Details
Main Authors:	D. P. Romodanovsky, T. V. Eremenkova, M. A. Dranitsyna, D. V. Goryachev, R. R. Niyazov, E. V. Gavrishina, V. A. Merkulov
Format:	Article
Language:	Russian
Published:	NEICON ISP LLC 2018-02-01
Series:	Ведомости Научного центра экспертизы средств медицинского применения
Subjects:	исследования биоэквивалентности биоэквивалентность высоковариабельные препараты bioequivalence studies bioequivalence highly variable medicines
Online Access:	https://www.vedomostincesmp.ru/jour/article/view/57

Similar Items

Planning and evaluation of bioequivalence studies of rosuvastatin drug products
by: D. P. Romodanovsky, et al.
Published: (2018-02-01)

Expert Approaches to the Assessment of Losartan Drugs Bioequivalence
by: D. P. Romodanovsky, et al.
Published: (2020-02-01)

Planning Bioequivalence Studies in the Context of the COVID-19 Pandemic
by: D. P. Romodanovsky, et al.
Published: (2021-03-01)

Analysis of the quality of bioequivalence and pharmacokinetics studies in Russia Federation
by: A. L. Khokhlov, et al.
Published: (2018-05-01)

Regulatory requirements of the European Medicines Agency for evaluation of bioequivalence of modified-release medicinal products
by: D. P. Romodanovsky, et al.
Published: (2019-03-01)

The ability to predict the results of bioequivalence studies based on a consistent statistical analysis of informative factors
by: Dmitry P Romodanovsky, et al.
Published: (2020-05-01)

Specific features of the bioequivalence study of drugs - analogs of endogenous compounds
by: V. K. Adonin, et al.
Published: (2018-02-01)

PLANNING AND EVALUATION OF BIOEQUIVALENCE STUDIES OF ATAZANAVIR PRODUCTS
by: N. E. Uvarova, et al.
Published: (2018-12-01)

INFLUENCE OF SEX DIFFERENCES ON PHARMACOKINETICS OF DRUGS WITHIN THE FRAMEWORK OF BIOEQUIVALENCE STUDIES OF GENERIC MEDICINAL PRODUCTS
by: D. P. Romodanovsky, et al.
Published: (2018-09-01)

Organizational aspects of conducting of bioequivalence study
by: Khokhlov A.L., et al.
Published: (2014-03-01)

Interchangeability of glibenclamide-containing drugs
by: G. I. Gorodetskaya, et al.
Published: (2018-02-01)

CLINICAL DEVELOPMENT STRATEGY FOR COPIES OF PREVIOUSLY REGISTERED DRUGS. PART 3. PROTOCOL OF CLINICAL TRIAL OF BIOEQUIVALENCE
by: K. A. Yatsenko, et al.
Published: (2019-01-01)

MOTIVATION AND PARTICIPATION EXPERIENCE OF HEALTHY VOLUNTEERS IN THE CLINICAL TRIALS OF BIOEQUIVALENCE IN RUSSIA
by: I. V. Mareev, et al.
Published: (2019-01-01)

Evaluation of Bioequivalence of Generic Imatinib Products and Generic Tacrolimus Products Based on Indirect Comparison of the Results of Their Bioequivalence Studies
by: D. V. Goryachev, et al.
Published: (2019-09-01)

Interchangeability of levothyroxine sodium tablets
by: G. I. Gorodetskaya, et al.
Published: (2018-02-01)

Peculiarities of approaches to assessing the interchangeability of antiepileptic drugs
by: E. O. Zhuravleva, et al.
Published: (2018-02-01)

Open questions on bioequivalence: the case of cholecalciferol
by: Antonio Marzo, et al.
Published: (2013-09-01)

Bioequivalence Comparison of Seventeen Commercial Oral Enrofloxacins against the Original Pioneer Preparation in Broilers
by: Hector Sumano, et al.
Published: (2006-02-01)

Comparative pharmacokinetic evaluation and bioequivalence study of three different formulations of Imatinib Mesylate in CML patients
by: Ehsan Mohajeri, et al.
Published: (2016-02-01)

Recommendations on the procedure for determining the interchangeability of medicinal products
by: B. K. Romanov, et al.
Published: (2018-02-01)

EXPERT APPROACHES TO EQUIVALENCE EVALUATION OF DRUGS — ANALOGUES OF ENDOGENOUS COMPOUNDS AS CONSISTENT WITH THE RUSSIAN LEGISLATION AND INTERNATIONAL LAW
by: D. P. Romodanovsky, et al.
Published: (2018-03-01)

THE DEVELOPMENT AND VALIDATION OF METHODS FOR QUANTITATIVE DETERMINATION OF THIAMINE IN BLOOD PLASMA BY MEANS OF LC-MS METHOD PROVIDING STUDIES OF BIOEQUIVALENCE
by: O. A. Tashirova, et al.
Published: (2022-12-01)

Comparative study of perindopril and perindopril metabolite pharmacokinetics using the HPLC/MS method
by: L. M. Krasnykh, et al.
Published: (2018-02-01)

Comparative assessment of saliva and plasma for drug bioavailability and bioequivalence studies in humans
by: Nasir M. Idkaidek
Published: (2017-07-01)

Relevant Issues of Planning Bioequivalence Studies of Drugs with a Narrow Therapeutic Range
by: D. P. Romodanovsky
Published: (2020-09-01)

PRINCIPLES OF STATISTICAL EVALUATION OF BIOEQUIVALENCE STUDIES IN THE CONTEXT OF CURRENT REGULATORY REQUIREMENTS AND LEGAL ACTS
by: D. P. Romodanovsky, et al.
Published: (2018-06-01)

Bioequivalence study of a generic Risperidone (Iperdal®) in healthy Thai male volunteers
by: Werawath Mahatthanatrakul, et al.
Published: (2008-05-01)

Modern approaches to the assessment of orally inhaled products bioequivalence
by: E. S. Petrova, et al.
Published: (2018-02-01)

Evaluation of Pharmacokinetics and Safety with Bioequivalence of Ibuprofen Sustained-Release Capsules of Two Formulations, in Chinese Healthy Volunteers: Bioequivalence Study
by: Huang C, et al.
Published: (2023-06-01)

Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects
by: Wang J, et al.
Published: (2021-03-01)

Innovating on Inhaled Bioequivalence: A Critical Analysis of the Current Limitations, Potential Solutions and Stakeholders of the Process
by: Jonattan Gallegos-Catalán, et al.
Published: (2021-07-01)

Bioequivalence Study of Vortioxetine Hydrobromide Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
by: Bai W, et al.
Published: (2023-09-01)

Application in silico Modeling Simulation in Bioequivalence Studies: A Review
by: Sekar Ayu Pawestri
Published: (2023-03-01)

Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study
by: Xin Li, et al.
Published: (2020-11-01)

Single-Dose Bioequivalence Study of Rivaroxaban-Containing Medicinal Products in Healthy Volunteers
by: G. N. Gildeeva, et al.
Published: (2022-10-01)

Bioequivalence of Different Formulations of Zonisamide Oral Suspensions: A Short Review
by: Stević I, et al.
Published: (2023-11-01)

Comparative Bioequivalence Studies of doxysam and doxycycline (Pfizer) by reversed phase HPLC.
by: Baghdad Science Journal
Published: (2010-03-01)

On the interchangeability of calcineurine inhibitors
by: K. E. Zatolochina, et al.
Published: (2018-02-01)

Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers
by: Radicioni M, et al.
Published: (2017-04-01)

Pharmacogenetic Variants Associated with Fluoxetine Pharmacokinetics from a Bioequivalence Study in Healthy Subjects
by: Carlos Alejandro Díaz-Tufinio, et al.
Published: (2023-09-01)